Available datapackage for study 'A Phase 3b, Multicenter, Randomized, Blinded, Active-Controlled Study to Compare the Efficacy and Safety of Ustekinumab to That of Adalimumab in the Treatment of Biologic Naïve Subjects With Moderately-to-Severely Active Crohn's Disease'
收藏DataCite Commons2026-02-09 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/dataPackages/PR00008743.2
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to compare the efficacy of treatment with ustekinumab or
adalimumab in biologic naive participants with moderately-to-severely active Crohn's disease
(CD) who have previously failed or were intolerant to conventional therapy (corticosteroids
and/or immunomodulators, such as azathioprine, 6-mercaptopurine, or methotrexate), as
measured by clinical remission at one year.
提供机构：
Vivli
创建时间：
2026-02-09
